Company IXICO plc

Equities

IXI

GB00BFXR4C20

Biotechnology & Medical Research

Delayed London S.E. 04:22:17 2024-04-23 am EDT 5-day change 1st Jan Change
8.5 GBX -2.86% Intraday chart for IXICO plc -2.86% -32.00%

Business Summary

IXICO plc is a United Kingdom-based company that provides specialist data analytics services to the global biopharmaceutical industry. The services include the collection, analysis, management, and reporting on data generated in the course of a clinical study. The outputs from the data analysis are used to enhance patient selection, monitor drug safety, and assess clinical efficacy of the drug under development. It offers a range of services, such as drug development analytics, imaging operations, post-marketing, and post-marketing. It offers end to end services, including trial design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. It offers a range of clinical trial imaging analysis tools, including radiological reads, structural and advanced magnetic resonance imaging (MRI). Its specialist data analytics services identify and measure biomarkers from brain scans and wearable biosensors.

Number of employees: 89

Sales per Business

GBP in Million2022Weight2023Weight Delta
Clinical Trials Services
100.0 %
9 100.0 % 7 100.0 % -22.89%

Sales per region

GBP in Million2022Weight2023Weight Delta
United States
45.8 %
3 31.4 % 3 45.8 % +12.62%
United Kingdom
14.3 %
2 23.8 % 1 14.3 % -53.72%
Netherlands
12.9 %
0 5.0 % 1 12.9 % +97.71%
Switzerland
12.2 %
2 24.0 % 1 12.2 % -60.71%
Ireland
10.3 %
1 8.4 % 1 10.3 % -4.83%
Europe
4.4 %
1 7.4 % 0 4.4 % -54.08%

Managers

Managers TitleAgeSince
Chief Executive Officer 63 17-02-05
Director of Finance/CFO 47 19-05-30
Chairman 59 13-10-13
Chief Operating Officer - -
Chief Tech/Sci/R&D Officer - 20-12-31
Chief Tech/Sci/R&D Officer 45 11-12-31

Members of the board

Members of the board TitleAgeSince
Chairman 59 13-10-13
Director/Board Member 48 16-09-15
Director/Board Member 60 23-10-04
Chief Executive Officer 63 17-02-05
Director of Finance/CFO 47 19-05-30
Director/Board Member 57 22-01-20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 48,351,373 25,384,416 ( 52.50 %) 0 52.50 %

Shareholders

NameEquities%Valuation
BGF Investment Management Ltd.
18.46 %
8,924,000 18.46 % 913 104 p
Octopus Investments Ltd.
13.25 %
6,408,400 13.25 % 655 707 p
Gresham House Asset Management Ltd.
10.69 %
5,166,972 10.69 % 528 685 p
Canaccord Genuity Wealth Ltd.
9.685 %
4,683,071 9.685 % 479 172 p
Amati Global Investors Ltd. (Venture Capital)
9.586 %
4,635,000 9.586 % 474 253 p
CFE (UK) Ltd.
7.978 %
3,857,566 7.978 % 394 706 p
Hargreaves Lansdown Asset Management Ltd.
3.632 %
1,756,000 3.632 % 179 674 p
City Asset Management Plc
2.953 %
1,427,860 2.953 % 146 099 p
Hardsteel Ltd.
1.752 %
847,000 1.752 % 86 665 p
626,000 1.295 % 64 052 p

Company contact information

Ixico Plc

Griffin Court 15 Long Lane

EC1A 9PN, London

+44 20 3763 7499

http://www.ixico.com
address IXICO plc(IXI)